3-HYDROXY ANAGRELIDE

Details

Stereochemistry	UNKNOWN
Molecular Formula	C10H7Cl2N3O2
Molecular Weight	272.087
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

OC1N2CC3=C(Cl)C(Cl)=CC=C3NC2=NC1=O

InChI

InChIKey=KAXTUTDKZVOONF-UHFFFAOYSA-N

InChI=1S/C10H7Cl2N3O2/c11-5-1-2-6-4(7(5)12)3-15-9(17)8(16)14-10(15)13-6/h1-2,9,17H,3H2,(H,13,14,16)

HIDE SMILES / InChI

Molecular Formula	C10H7Cl2N3O2
Molecular Weight	272.087
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Approval Year

Substance Class	Chemical Created by `admin` on `Wed Apr 02 01:46:17 GMT 2025` Edited by `admin` on `Wed Apr 02 01:46:17 GMT 2025`
Record UNII	PIN0NPZ24B
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

BCH-24426

Preferred Name

English

3-HYDROXY ANAGRELIDE

Common Name

English

6,7-Dichloro-1,5-dihydro-3-hydroxyimidazo[2,1-b]quinazolin-2(3H)-one

Systematic Name

English

BCH24426

Common Name

English

Code System Code Type Description

PUBCHEM

135424310

Created by admin on Wed Apr 02 01:46:17 GMT 2025 , Edited by admin on Wed Apr 02 01:46:17 GMT 2025

PRIMARY

EPA CompTox

DTXSID10468915

Created by admin on Wed Apr 02 01:46:17 GMT 2025 , Edited by admin on Wed Apr 02 01:46:17 GMT 2025

PRIMARY

FDA UNII

PIN0NPZ24B

Created by admin on Wed Apr 02 01:46:17 GMT 2025 , Edited by admin on Wed Apr 02 01:46:17 GMT 2025

PRIMARY

CAS

733043-41-9

Created by admin on Wed Apr 02 01:46:17 GMT 2025 , Edited by admin on Wed Apr 02 01:46:17 GMT 2025

PRIMARY

Related Record Type Details


					JOC85XIO65

CGMP-INHIBITED 3',5'-CYCLIC PHOSPHODIESTERASE A

TARGET -> INHIBITOR

Comments:

May be responsible for Cardiac related adverse events.

Qualification:

IC50

Amount:

Related Record Type Details


					K9X45X0051

ANAGRELIDE

PARENT -> METABOLITE ACTIVE

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Volume of Distribution	PHARMACOKINETIC

Biological Half-life	PHARMACOKINETIC